Canada provided an update on safety review of AstraZeneca and Covishield COVID-19 vaccines Health Canada is updating Canadians and healthcare professionals about its ongoing safety review of very rare events of blood clots associated with low levels of blood platelets following immunization with the AstraZeneca and COVISHIELD COVID-19 vaccines according to the Department of Health of Canada.